1. Home
  2. ARAY vs SERA Comparison

ARAY vs SERA Comparison

Compare ARAY & SERA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Accuray Incorporated

ARAY

Accuray Incorporated

HOLD

Current Price

$0.39

Market Cap

68.6M

Sector

Health Care

ML Signal

HOLD

Logo Sera Prognostics Inc.

SERA

Sera Prognostics Inc.

HOLD

Current Price

$1.72

Market Cap

77.2M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
ARAY
SERA
Founded
1990
2008
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Precision Instruments
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
68.6M
77.2M
IPO Year
2006
2021

Fundamental Metrics

Financial Performance
Metric
ARAY
SERA
Price
$0.39
$1.72
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.50
N/A
AVG Volume (30 Days)
1.4M
78.6K
Earning Date
04-29-2026
03-18-2026
Dividend Yield
N/A
N/A
EPS Growth
87.50
32.32
EPS
N/A
N/A
Revenue
N/A
$81,000.00
Revenue This Year
N/A
$25.84
Revenue Next Year
$4.58
$715.79
P/E Ratio
N/A
N/A
Revenue Growth
N/A
5.19
52 Week Low
$0.33
$1.37
52 Week High
$2.10
$4.20

Technical Indicators

Market Signals
Indicator
ARAY
SERA
Relative Strength Index (RSI) 31.74 27.88
Support Level $0.33 $1.37
Resistance Level $0.63 $2.00
Average True Range (ATR) 0.04 0.20
MACD 0.00 0.00
Stochastic Oscillator 27.75 9.00

Price Performance

Historical Comparison
ARAY
SERA

About ARAY Accuray Incorporated

Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, treatment solutions which set the standard of radiation therapy care with the objective of helping patients live lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

About SERA Sera Prognostics Inc.

Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services. The Company operates as one operating segment, which is developing and commercializing its medical diagnostic products and services.

Share on Social Networks: